000 01466 a2200433 4500
005 20250516154536.0
264 0 _c20130926
008 201309s 0 0 eng d
022 _a1524-4539
024 7 _a10.1161/CIR.0b013e31829b2be6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPennell, Dudley J
245 0 0 _aCardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
_h[electronic resource]
260 _bCirculation
_cJul 2013
300 _a281-308 p.
_bdigital
500 _aPublication Type: Journal Article; Practice Guideline
650 0 4 _aAmerican Heart Association
650 0 4 _aConsensus
650 0 4 _aHeart Failure
_xetiology
650 0 4 _aHumans
650 0 4 _aIron Chelating Agents
_xtherapeutic use
650 0 4 _aIron Overload
_xcomplications
650 0 4 _aUnited States
650 0 4 _abeta-Thalassemia
_xcomplications
700 1 _aUdelson, James E
700 1 _aArai, Andrew E
700 1 _aBozkurt, Biykem
700 1 _aCohen, Alan R
700 1 _aGalanello, Renzo
700 1 _aHoffman, Timothy M
700 1 _aKiernan, Michael S
700 1 _aLerakis, Stamatios
700 1 _aPiga, Antonio
700 1 _aPorter, John B
700 1 _aWalker, John Malcolm
700 1 _aWood, John
773 0 _tCirculation
_gvol. 128
_gno. 3
_gp. 281-308
856 4 0 _uhttps://doi.org/10.1161/CIR.0b013e31829b2be6
_zAvailable from publisher's website
999 _c22844254
_d22844254